Harald Frick
attending physician
Pathologie · Dept. IV
Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies
Ess S, Mousavi M, Frick H, Rohrmann S, Ortelli L, Bordoni A, Konzelmann I, Rapiti E, Neyroud I, Bouchardy C, Herrmann C, Thürlimann B. Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies. Breast 2018; 41:151-158.
Jul 30, 2018Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies
Jul 30, 2018Breast 2018; 41:151-158
Ess Silvia M, Mousavi Mohsen, Frick Harald, Rohrmann Sabine, Ortelli Laura, Bordoni Andrea, Konzelmann Isabelle, Rapiti Elisabetta, Neyroud Isabelle, Bouchardy Christine, Herrmann Christian, Thürlimann Beat
Multiple primary tumours: challenges and approaches, a review
Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open 2017; 2:e000172.
May 2, 2017Multiple primary tumours: challenges and approaches, a review
May 2, 2017ESMO Open 2017; 2:e000172
Vogt Alexia, Schmid Sabine, Heinimann Karl, Frick Harald, Herrmann Christian, Cerny Thomas, Omlin Aurelius
Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011
Feller A, Clough-Gorr K, Arndt V, Steiner A, Mousavi M, Frick H, Bouchardy C, Bordoni A, Fehr M, The Nicer Working Group. Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011. Swiss Med Wkly 2015; 145:w14245.
Dec 10, 2015Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011
Dec 10, 2015Swiss Med Wkly 2015; 145:w14245
Feller Anita, Clough-Gorr Kerri M, Arndt Volker, Steiner Annik, Mousavi Mohsen, Frick Harald, Bouchardy Christine, Bordoni Andrea, Fehr Martin, The Nicer Working Group
Tobacco-related cancer mortality: projections for different geographical regions in Switzerland
Jürgens V, ess s, Phuleria H, Früh M, Schwenkglenks M, Frick H, Cerny T, Vounatsou P. Tobacco-related cancer mortality: projections for different geographical regions in Switzerland. Swiss Med Wkly 2013; 143:w13771.
Jun 25, 2013Tobacco-related cancer mortality: projections for different geographical regions in Switzerland
Jun 25, 2013Swiss Med Wkly 2013; 143:w13771
Jürgens Verena, ess silvia, Phuleria Harish C, Früh Martin, Schwenkglenks Matthias, Frick Harald, Cerny Thomas, Vounatsou Penelope
Cancer survivors in Switzerland: a rapidly growing population to care for
Herrmann C, Cerny T, Savidan A, Vounatsou P, Konzelmann I, Bouchardy C, Frick H, ess s. Cancer survivors in Switzerland: a rapidly growing population to care for. BMC cancer 2013; 13:287.
Jun 14, 2013Cancer survivors in Switzerland: a rapidly growing population to care for
Jun 14, 2013BMC cancer 2013; 13:287
Herrmann Christian, Cerny Thomas, Savidan Anita, Vounatsou Penelope, Konzelmann Isabelle, Bouchardy Christine, Frick Harald, ess silvia
Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland
Jürgens V, ess s, Phuleria H, Früh M, Schwenkglenks M, Frick H, Cerny T, Vounatsou P. Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland. Geospat Health 2013; 7:219-36.
May 1, 2013Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland
May 1, 2013Geospat Health 2013; 7:219-36
Jürgens Verena, ess silvia, Phuleria Harish C, Früh Martin, Schwenkglenks Matthias, Frick Harald, Cerny Thomas, Vounatsou Penelope
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists
Varga Z, Viale G, Mastropasqua M, Wagner U, Tapia C, Singer G, Schreiber-Facklam H, Schobinger-Clement S, Sancho Oliver S, Rakozy C, Padberg B, Öhlschlegel C, Obermann E, Noske A, Kaup D, Frick H, Dommann-Scherrer C, Diebold J, Lehr H. How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists. PloS one 2012; 7:e37379.
May 25, 2012How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists
May 25, 2012PloS one 2012; 7:e37379
Varga Zsuzsanna, Viale Giuseppe, Mastropasqua Mauro G, Wagner Urs, Tapia Coya, Singer Gad, Schreiber-Facklam Heide, Schobinger-Clement Sylviane, Sancho Oliver Sara, Rakozy Christiane, Padberg Barbara, Öhlschlegel Christian, Obermann Ellen, Noske Aurelia, Kaup Daniela, Frick Harald, Dommann-Scherrer Corina, Diebold Joachim, Lehr Hans-Anton
A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer
Jörger M, ess s, Dehler S, Savidan A, Bouchardy C, Frick H, Konzelmann I, Thürlimann B. A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer. Swiss Med Wkly 2012; 142:w13571.
Apr 11, 2012A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer
Apr 11, 2012Swiss Med Wkly 2012; 142:w13571
Jörger Markus, ess silvia, Dehler Silvia, Savidan Anita, Bouchardy Christine, Frick Harald, Konzelmann Isabelle, Thürlimann Beat
A Population-Based Study on the Implementation of Treatment Recommendations for Chemotherapy in Early Breast Cancer
Jörger M, Thürlimann B, Savidan A, Frick H, Bouchardy C, Konzelmann I, Probst-Hensch N, ess s. A Population-Based Study on the Implementation of Treatment Recommendations for Chemotherapy in Early Breast Cancer. Clin Breast Cancer 2011
Dec 2, 2011A Population-Based Study on the Implementation of Treatment Recommendations for Chemotherapy in Early Breast Cancer
Dec 2, 2011Clin Breast Cancer 2011
Jörger Markus, Thürlimann Beat, Savidan Anita, Frick Harald, Bouchardy Christine, Konzelmann Isabelle, Probst-Hensch Nicole, ess silvia